NCT00217477View on ClinicalTrials.gov

Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

May 31, 2013

Study Completion Date

September 30, 2014

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

gemcitabine hydrochloride

Given IV

DRUG

paricalcitol

Given IV

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Roswell Park Cancer Institute

OTHER